<DOC>
	<DOC>NCT02009410</DOC>
	<brief_summary>maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in diabetes type II</brief_summary>
	<brief_title>A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Signed Informed Consent BMI &lt; 30 kg/m2 History of type 2 diabetes mellitus as confirmed by: onset of diabetes after 30 years of age and no insulin treatment in the first year after diagnosis Subjects on insulin treatment or on insulin treatment in combination with oral antidiabetics HbA1c &gt; 6.5% in medical history within the last 6 months despite insulin treatment Not previously treated with any pancreatic enzyme supplementation Inclusion Criterion at Visit 1: • FE1 (fecal elastase 1) &lt;100μg/g of stool Inclusion Criterion at Visit 2: • 13C MTBT of &lt;29% 13CO2CRR (Carbon dioxideCumulative Recovery Rate) Treatment with systemic steroids for at least 3 weeks within past 6 months Patients with a known pancreatic exocrine insufficiency due to nondiabetic diseases, e.g., chronic pancreatitis, pancreatectomy, cystic fibrosis, celiac disease, shwachmandiamond syndrome, gastrectomy, etc. Any type of malignancy involving digestive tract in the last 5 years Any type of gastrointestinal surgery (except appendectomy and gallbladder resection) Short bowel syndrome Hemochromatosis Known late onset autoimmune diabetes in the adult Any history of drug abuse including alcohol Positive urine pregnancy test; lactation; females of childbearing potential who are not using either an oral hormonal contraceptive or an intrauterine device Hypersensitivity to the active substance or to any of the excipients Intake of an experimental drug within 4 weeks prior to entry into this study Suspected noncompliance or noncooperation History of human immunodeficiency virus (HIV) infection</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Exocrine Pancreatic Insufficiency</keyword>
</DOC>